Product	RRP	Price	Order
Ebixa treatment inition pack	€ 112,65	€ 100,75	Add to shopping cart
Ebixa 10 mg 28 Tabl.	€ 90,00	€ 80,75	Add to shopping cart
Ebixa 10 mg 112 Tabl.	€ 360,75	€ 322,75	Add to shopping cart
Ebixa 20 mg 28 Tabl.	€ 180,15	€ 161,75	Add to shopping cart

 

 

 

Ebixa tablets and oral drops contain the active ingredient memantine hydrochloride, which is a type of medicine called an NMDA-receptor antagonist. It is used for treating Alzheimer%u2019s disease.

There is increasing evidence that memory loss and dementia in Alzheimer's disease are related to malfunctioning of the signals that pass messages between the nerve cells in the brain. In particular, there is evidence that excessive activity of a natural body chemical called glutamate contributes to the symptoms of Alzheimer%u2019s and the progression of this disease.

Glutamate acts on receptors called NMDA receptors that are found on nerve cells in the brain. These receptors and nerve cells are involved in transmitting nerve messages in the brain that are important in learning and memory. Glutamate can damage the nerve cells by excessively stimulating the NMDA receptors.

Memantine works by blocking the NMDA receptors in the brain. This blocks the excessive activity of glutamate, but still allows the normal activation of these receptors that occurs when the brain forms a memory.

Memantine may therefore improve brain functioning in Alzheimer's disease, and may also block the glutamate activity that could cause further damage to the brain cells.

Memantine is licensed to treat moderate to severe Alzheimer's disease. Studies have demonstrated that memantine causes a small improvement or stabilisation in the cognitive functioning (thinking, learning and memory) and daily functioning of this group of patients.